Trial Outcomes & Findings for Transcranial Direct Current Stimulation for Post-Stroke Aphasia (NCT NCT02461355)

NCT ID: NCT02461355

Last Updated: 2019-05-09

Results Overview

Recruitment status

TERMINATED

Study phase

Target enrollment

2 participants

Primary outcome timeframe

From Baseline to up to 2 days post-training

Results posted on

2019-05-09

Participant Flow

Participant milestones

Participant milestones
Measure	All Participants Includes participants who received anodal transcranial direct current stimulation (tDCS) or sham tDCS over the left posterior language areas during aphasia therapy for 8 one-hour sessions.Since the PI left the institution and data on the cross-over assignment is not available for the 2 participants, data was reported on the collective whole and not on the treatment assignment per individual.
Overall Study STARTED	2
Overall Study COMPLETED	2
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Transcranial Direct Current Stimulation for Post-Stroke Aphasia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	All Participants n=2 Participants Includes participants who received anodal transcranial direct current stimulation (tDCS) or sham tDCS over the left posterior language areas during aphasia therapy for 8 one-hour sessions.
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	2 Participants n=5 Participants
Age, Categorical >=65 years	0 Participants n=5 Participants
Sex: Female, Male Female	1 Participants n=5 Participants
Sex: Female, Male Male	1 Participants n=5 Participants
Race (NIH/OMB) American Indian or Alaska Native	0 Participants n=5 Participants
Race (NIH/OMB) Asian	0 Participants n=5 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=5 Participants
Race (NIH/OMB) Black or African American	0 Participants n=5 Participants
Race (NIH/OMB) White	2 Participants n=5 Participants
Race (NIH/OMB) More than one race	0 Participants n=5 Participants
Race (NIH/OMB) Unknown or Not Reported	0 Participants n=5 Participants

PRIMARY outcome

Timeframe: From Baseline to up to 2 days post-training

Population: Due to poor enrollment, data collection was not complete and therefore data was not analyzed. PI is now no longer at the institution.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: From Baseline to up to 2 days post-training

Population: Due to poor enrollment, data collection was not complete and therefore data was not analyzed. PI is now no longer at the institution.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline to 2 weeks and 4 weeks post-training

Population: Due to poor enrollment, data collection was not complete and therefore data was not analyzed. PI is now no longer at the institution.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline to 2 weeks and 4 weeks post-training

Population: Due to poor enrollment, data collection was not complete and therefore data was not analyzed. PI is now no longer at the institution.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline to immediate, 2 weeks, and 4 weeks post-training

Outcome measures

Outcome data not reported

Adverse Events

All Participants

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Tomoko Kitago, MD

Burke Neurological Institute

Phone: 914-368-3169

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place